Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 723-733, December 2009

Lithium and thyroid

  • John H. Lazarus, MA, MD, FRCP, FACE, FRCOG (Professor of Clinical Endocrinology)

      Affiliations

    • Corresponding Author InformationTel./Fax: +44 2920 744326.

Centre for Endocrine and Diabetes Sciences, Cardiff University School of Medicine, University Hospital of Wales, Cardiff CF14 4 XN, Wales, UK

One in 200 people receive lithium for treatment of bipolar disorder. The common clinical side effects of the drug are goitre in up to 40% and hypothyroidism in about 20%. Lithium increases thyroid autoimmunity if present before therapy. Treatment with levothyroxine is effective and lithium therapy should not be stopped. Lithium may cause hyperthyroidism due to thyroiditis or rarely Graves' disease. As lithium inhibits thyroid hormone release from the thyroid gland it can be used as an adjunct therapy in the management of severe hyperthyroidism. It also increases thyroidal radioiodine retention and may be effective in reducing administered activity in hyperthyroidism. There is no clinical benefit of lithium therapy in thyroid cancer. More research is required on the cellular proliferative effects of lithium as well as its impact on the immune system.

Keywords: autoimmunity, goitre, hyperthyroidism, hypothyroidism, physiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(09)00072-4

doi:10.1016/j.beem.2009.06.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 723-733, December 2009